Citadel Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $7.8M | Buy |
|
|||||
|
2023
Q3 | $1.69M | Sell |
|
|||||
|
2023
Q2 | $4.92M | Buy |
|
|||||
|
2023
Q1 | $2.84M | Sell |
|
|||||
|
2022
Q4 | $8.53M | Buy |
|
|||||
|
2022
Q3 | $4.73M | Buy |
|
|||||
|
2022
Q2 | $3.86M | Buy |
|
|||||
|
2022
Q1 | $3.01M | Buy |
|
|||||
|
2021
Q4 | $2.32M | Buy |
|
|||||
|
2021
Q3 | $404K | Sell |
|
|||||
|
2021
Q2 | $1.54M | Sell |
|
|||||
|
2021
Q1 | $7.18M | Sell |
|
|||||
|
2020
Q4 | $14.5M | Buy |
|
|||||
|
2020
Q3 | $16.1M | Sell |
|
|||||
|
2020
Q2 | $9.42M | Buy |
|
|||||
|
2020
Q1 | $3.94M | Sell |
|
|||||
|
2019
Q4 | $5.6M | Buy |
|
|||||
|
2019
Q3 | $11.7M | Sell |
|
|||||
|
2019
Q2 | $16.6M | Sell |
|
|||||
|
2019
Q1 | $37.3M | Buy |
|
|||||
|
2018
Q4 | $11.2M | Buy |
|
|||||
|
2018
Q3 | $10.6M | Sell |
|
|||||
|
2018
Q2 | $25.7M | Buy |
|
|||||
|
2018
Q1 | $13.9M | Buy |
|
|||||
|
2017
Q4 | $6.39M | Buy |
|
|||||
|
2017
Q3 | $5.16M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $71K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $25K | Sell |
|
|||||
|
2016
Q2 | $47K | Buy |
|
|||||
|
2016
Q1 | $15K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $183K | Buy |
|